INVICTUS MD STRATEGIES CORP. GENE:CA IVITF is pleased to announce that it has entered into a definitive agreement to acquire 100% (the “Acquisition”) of the issued and outstanding shares of a company (“Leaf Wise”) that operates medical clinics in Alberta (see press release dated July 20, 2018, for more details).

Leaf Wise employs a patient-first business model that features on-site physicians, educational guides and registration support in just four easy steps. With approximately 3,400 patients registered under Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Leaf Wise will serve as a direct channel to Invictus owned Licensed Producers (“LPs”), fully licensed under ACMPR.

The College of Physicians and Surgeons of Alberta requires a physician who completes a patient medical document for cannabis to see the patient every three months, at minimum, following stabilization. Leaf Wise will serve as an important agent of Invictus’ medical distribution channel, helping to foster long-lasting relationships with patients, while alleviating a potential burden for Alberta’s public healthcare system.

“Over the past few months, we have experienced substantial growth in our medical distribution channels as more physicians and patients look to cannabis for treatment,” said Dan Kriznic, Chairman and CEO of Invictus. “As the industry evolves, we will continue to support research that helps to advance patient care and provide a forum to facilitate and monitor ongoing treatment.”

Under the terms of the Acquisition, the purchase price includes an upfront cash payment of $625,000 paid on closing, and $625,000 in common shares (the “Share Consideration”) of Invictus on closing. Share Consideration will consist of 312,500 Invictus shares representing an aggregate market value of $625,000 based on a price per Invictus share of $2.00. In addition, future consideration will be paid based on the achievement of certain performance milestones, including certain patient metrics.

The closing of the Acquisition (the “Closing Date”) shall take place on or before October 31, 2018, or such other time mutually agreed by both parties. In addition, Invictus will provide a capital commitment of $500,000 (the “Investment”) for expansion of the existing medical clinic business and working capital purposes, to be funded over time, after the Closing Date. The Acquisition is subject to final Board and TSXV approval.

About Invictus

Invictus is a global cannabis company offering a selection of products under a wide range of lifestyle brands. Our integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores.

Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmons as our Chief Evangelist Officer. To meet growing demand, Invictus is expanding its cultivation footprint, with two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and up to 1 million by end of 2020. To accommodate international sales, Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), has designed and is currently building its Phase 3 and 4 purpose-built cultivation facilities to be European Union Good Manufacturing Practices (“EU-GMP”) compliant. The Company will earmark up to 50 per cent of production to the medical. To ensure consistency in quality and supply, Invictus maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd., a high-quality Fertilizer and Nutrients manufacturer. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with over 69 Health Canada approved strains and a multifaceted distribution strategy including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. For more information visit www.invictus-md.com.

In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.